Related Experiment Video

Updated: Jan 20, 2026

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models
04:25

Intratibial Osteosarcoma Cell Injection to Generate Orthotopic Osteosarcoma and Lung Metastasis Mouse Models

Published on: October 28, 2021

11.2K

Reduction-responsive polypeptide nanomedicines significantly inhibit progression of orthotopic osteosarcoma

Fei Yin1, Zongyi Wang1, Yafei Jiang1

  • 1Department of Orthopedics, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai Bone Tumor Institution, Shanghai, PR China.

Nanomedicine : Nanotechnology, Biology, and Medicine
|August 24, 2019
PubMed

Insights

New polypeptide micelles effectively deliver doxorubicin (DOX) for osteosarcoma (OS) treatment. These targeted micelles improve drug concentration in tumors and reduce heart toxicity, offering a promising chemotherapy approach for OS patients.

Area of Science:

  • Biomedical Engineering
  • Materials Science
  • Oncology

Background:

  • Osteosarcoma (OS) is a common bone cancer with high mortality due to metastasis.
  • Current neoadjuvant chemotherapy for OS has limited efficacy and significant side effects, particularly cardiotoxicity.

Purpose of the Study:

  • To develop reduction-responsive polypeptide micelles for controlled doxorubicin (DOX) delivery in osteosarcoma therapy.
  • To evaluate the pharmacokinetic, tumor accumulation, and therapeutic efficacy of these novel micelles.

Main Methods:

  • Synthesis of methoxy poly(ethylene glycol)-block-poly(S-tert-butylmercapto-L-cysteine) copolymers (mPEG-b-PBMLC) to form polypeptide micelles.
  • Encapsulation of doxorubicin (DOX) into the micelles (P4M/DOX and P9M/DOX).
  • In vivo evaluation of pharmacokinetics, tumor targeting, and antitumor efficacy in osteosarcoma models.

Main Results:

  • P4M/DOX and P9M/DOX micelles showed significantly increased drug exposure (2.6-3.5x AUC) and tumor accumulation (1.6-2.0x) compared to free DOX.
  • Micelle administration resulted in reduced drug distribution in the heart (1.6-1.7x decrease), mitigating cardiotoxicity.
  • P9M/DOX micelles demonstrated superior antitumor effects against primary and metastatic osteosarcoma with reduced systemic toxicity.

Conclusions:

  • Reduction-responsive polypeptide micelles offer a promising strategy for targeted doxorubicin delivery in osteosarcoma.
  • These micelles enhance therapeutic efficacy and minimize side effects, addressing limitations of current chemotherapy.
  • The smart responsiveness to intracellular environments makes these micelles suitable for broader cancer chemotherapeutic drug delivery.
Keywords:
Antineoplastic agent deliveryLung metastasis inhibitionOsteosarcoma therapyPolypeptide micelleReduction-responsiveness

More Related Videos

Bioluminescent Orthotopic Model of Pancreatic Cancer Progression09:25

Bioluminescent Orthotopic Model of Pancreatic Cancer Progression

Published on: June 28, 2013

27.5K
A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate07:31

A Syngeneic Orthotopic Osteosarcoma Sprague Dawley Rat Model with Amputation to Control Metastasis Rate

Published on: May 3, 2021

4.2K

Related Concept Videos

Feedback Inhibition00:46

Feedback Inhibition

Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
56.9K
Oxidation-Reduction Reactions03:11

Oxidation-Reduction Reactions

Oxidation–Reduction Reactions
75.1K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.2K
Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
91.7K
Block Diagram Reduction01:22

Block Diagram Reduction

The process of deriving the transfer function of a control system often involves reducing its block diagram to a single block. This simplification can be achieved through a series of strategic operations, including relocating branch points and comparators. These operations preserve the overall function of the system while allowing for easier manipulation and combination of blocks.
The first step in this process is the identification and relocation of a branch point. A branch point, where a...
543
Oxymercuration-Reduction of Alkenes02:36

Oxymercuration-Reduction of Alkenes

Oxymercuration–reduction of alkenes is one of the major reactions converting alkenes to alcohols. It involves the hydration of alkenes with mercuric acetate in a mixture of tetrahydrofuran and water, forming an organomercury adduct. This is followed by a demercuration step in which the adduct is reduced to an alcohol using sodium borohydride.
9.3K